au.\*:("WELLSTEIN, A")
Results 1 to 25 of 34
Selection :
NECROSE DU MYOCARDE PAR TOCOLYSE AVEC LE FENOTEROL.MEINEN K; BREINL H; SCHMIDT EW et al.1979; J. GYNECOL. OBSTETR. BIOL. REPROD.; FRA; DA. 1979; VOL. 8; NO 1; PP. 23-25; ABS. ENG; BIBL. 15 REF.Article
Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancyPITSCHNER, H. F; WELLSTEIN, A.Naunyn-Schmiedeberg's archives of pharmacology. 1988, Vol 338, Num 2, pp 207-210, issn 0028-1298Article
ZUR FRAGE DER MYOCARDSCHAEDIGUNG DURCH FENOTEROL. (KLINISCH-CHEMISCHE UNTERSUCHUNGEN UNTER BESONDERER BERUECKSICHTIGUNG DES HERZMUSKELSPEZIFISCHEN CREATINKINASE-ISOENZYMS MB). = SUR LA QUESTION DE LA LESION DU MYOCARDE PAR LE FENOTEROL. (ETUDES CLINICO-CHIMIQUES EN TENANT COMPTE EN PARTICULIER DE L'ISOENZYME SPECIFIQUE MYOCARDIQUE DE LA CREATINE-KINASE MB)WELLSTEIN A; BREINL H; MEINEN K et al.1977; Z. GEBURTSH. PERINATOL.; DTSCH.; DA. 1977; VOL. 181; NO 6; PP. 402-406; ABS. ANGL.; BIBL. 15 REF.Article
Penbutolol: β-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in manWELLSTEIN, A; PALM, D.European journal of clinical pharmacology. 1985, Vol 29, Num 3, pp 293-300, issn 0031-6970Article
Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1MASHOUR, G. A; WANG, H.-L; CABAL-MANZANO, R et al.Journal of investigative dermatology. 1999, Vol 113, Num 3, pp 398-402, issn 0022-202XConference Paper
The potential role of the heparin-binding growth factor pleiotrophin in breast cancerRIEGEL, A. T; WELLSTEIN, A.Breast cancer research and treatment. 1994, Vol 31, Num 2-3, pp 309-314, issn 0167-6806Article
d-Sotalol reduces heart rate in vivo through a β-adrenergic receptor-independent mechanismYASUDA, S. U; BARBEY, J. T; FUNCK-BRENTANO, C et al.Clinical pharmacology and therapeutics. 1993, Vol 53, Num 4, pp 436-442, issn 0009-9236Article
Structure of the human heparin-binding growth factor gene pleiotrophinLAI, S; CZUBAYKO, F; TATE RIEGEL, A et al.Biochemical and biophysical research communications (Print). 1992, Vol 187, Num 2, pp 1113-1122, issn 0006-291XArticle
Purification of PO-B, a protein that has increased affinity for the pro-opiomelanocortin gene promoter after dephosphorylationWELLSTEIN, A; DOBRENSKI, A. F; RADONOVICH, M. N et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 19, pp 12234-12241, issn 0021-9258Article
Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growthCZUBAYKO, F; RIEGEL, A. T; WELLSTEIN, A et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 33, pp 21358-21363, issn 0021-9258Article
Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranololJOUBERT, P. H; VENTER, C. P; WELLSTEIN, A et al.European journal of clinical pharmacology. 1988, Vol 34, Num 4, pp 363-368, issn 0031-6970Article
Agonist binding at alpha2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cationsSCHLOOS, J; WELLSTEIN, A; PALM, D et al.Naunyn-Schmiedeberg's archives of pharmacology. 1987, Vol 336, Num 1, pp 48-59, issn 0028-1298Article
Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plotsWELLSTEIN, A; BELZ, G. G; PALM, D et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 1, pp 328-337, issn 0022-3565Article
A method for estimating the potency of angiotensin-converting enzyme inhibitors in manWELLSTEIN, A; ESSIG, J; BELZ, G. G et al.British journal of clinical pharmacology. 1987, Vol 24, Num 3, pp 397-399, issn 0306-5251Article
DESENSITIZATION OF THE BETA -ADRENOCEPTOR-ADENYLATE CYCLASE SYSTEM OF IMMATURE ERYTHROCYTES BY IN-VIVO TREATMENT OF RATS WITH ISOPRENALINEWIEMER G; KAISER G; DIETZ J et al.1981; NAUNYN-SCHMIEDEBERGS ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1981; VOL. 317; NO 4; PP. 294-301; BIBL. 37 REF.Article
Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approachMALERCZYK, C; SCHULTE, A. M; CZUBAYKO, F et al.Gene therapy (Basingstoke). 2005, Vol 12, Num 4, pp 339-346, issn 0969-7128, 8 p.Article
Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patientsJÄGER, R; LIST, B; KNABBE, C et al.British journal of cancer. 2002, Vol 86, Num 6, pp 858-863, issn 0007-0920Article
Phase I trial of pentosan polysulfateSWAIN, S. M; PARKER, B; WELLSTEIN, A et al.Investigational new drugs. 1995, Vol 13, Num 1, pp 55-62, issn 0167-6997Article
Relationship between serum concentrations of the Growth factor pleiotrophin and pleiotrophin-positive tumorsSOUTTOU, B; JUHL, H; HACKENBRUCK, J et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 19, pp 1468-1473, issn 0027-8874Article
Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesisKURTZ, A; WANG, H.-L; DARWICHE, N et al.Oncogene (Basingstoke). 1997, Vol 14, Num 22, pp 2671-2681, issn 0950-9232Article
Inhibition of fibroblast growth factorsWELLSTEIN, A; CZUBAYKO, F.Breast cancer research and treatment. 1996, Vol 38, Num 1, pp 109-119, issn 0167-6806Conference Paper
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfatePARKER, B. W; SWAIN, S. M; ZUGMAIER, G et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 13, pp 1068-1073, issn 0027-8874Article
Differentiation of β1- and β2-adrenoceptor-mediated effects in humansBRODDE, O.-E; DAUL, A; WELLSTEIN, A et al.American journal of physiology. Heart and circulatory physiology. 1988, Vol 23, Num 2, pp H199-H206, issn 0363-6135Article
Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasmaWELLSTEIN, A; PALM, D; WIEMER, G et al.European journal of clinical pharmacology. 1984, Vol 27, Num 5, pp 545-553, issn 0031-6970Article
Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin : a critical role of a retroviral Sp1-binding siteSCHULTE, A. M; MALERCZYK, C; CABAL-MANZANO, R et al.Oncogene (Basingstoke). 2000, Vol 19, Num 35, pp 3988-3998, issn 0950-9232Article